Gabapentin
Product Images NDC 50383-311

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50383-311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

An illustration showing a formula used for calculating creatinine clearance (CLCr). The formula includes variables for age, weight, serum creatinine, and a factor to adjust for female patients.*

FDA Label Image

Figure 1 (Image 02)

Chemical structure of the active ingredient gabapentin, showing a cyclohexane ring bonded to aminomethyl and carboxymethyl groups.*

FDA Label Image

Figure 2 (Image 03)

A line graph comparing mean pain scores over an 8-week period for Gabapentin 3600 mg/day versus placebo during 4-week dose titration and 4-week fixed dose periods. Gabapentin shows a decreasing pain score trend while placebo remains relatively stable.*

FDA Label Image

Figure 3 (Image 04)

A line graph comparing mean pain scores over 7 weeks for placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day during a 3-week dose titration period followed by a 4-week fixed dose period. Gabapentin groups show a greater reduction in pain scores compared to placebo.*

FDA Label Image

Figure 4 (Image 05)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score): Controlled PHN Studies,' comparing placebo (PBO) to various dosages of gabapentin (GBP 300, GBP 1800, GBP 2400) across two studies. The chart shows responder percentages on the vertical axis and indicates statistical significance with asterisks.*

FDA Label Image

Display Panel (Image 06)

A scatter plot comparing percentage difference against daily dose (mg) for Gabapentin from three different studies labeled as Study a, Study b, and Study c. The x-axis displays daily doses ranging from 600 to 1800 mg, and the y-axis shows difference percentages from 2% to 22%. Study a is represented by black squares, Study b by gray squares, and Study c by white squares.*

FDA Label Image

Image 07

Gabapentin Oral Solution 250 mg/5 mL (50 mg/mL) label from Akorn. The 470 mL bottle label includes pharmacist instructions to provide the Medication Guide, states Rx only, and details that each 5 mL contains 250 mg of gabapentin. It advises to see the package insert for full prescribing information and to keep the solution out of reach of children and refrigerated at 2-8°C (36-46°F).*

FDA Label Image

Image 08

Gabapentin oral solution 250 mg per 5 mL bottle label. The label states the product delivers 5 mL, is for institutional use only, and includes storage instructions to keep refrigerated between 2-8°C (36-46°F). The label also advises users to see the package insert for full prescribing information and indicates the product is Rx only. The label includes a barcode and identifies Hi-Tech Pharmacal Co., Inc., Amityville, NY as the manufacturer.*

FDA Label Image

Image 09

Gabapentin Oral Solution 300 mg per 6 mL round bottle label by Akorn, delivering 6 mL per dose. The label states it is for institutional use only, requires prescription, and should be stored refrigerated at 2-8°C (36-46°F). The product barcode and manufacturer details are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.